The use of a non-glycanated polypeptide for treating a cancer
AssigneeInstitut Pasteur de Lille
InventorsPhilippe Lassalle, Bogdan Grigoriu, Florence Depontieu
Life of this patent
Estimating the term…
Abstract
The use of a non-glycanated form of a polypeptide including an amino acid sequence having at least 90% amino acid identity with an amino acid sequence selected from the group consisting of SEQ ID No 1 and SEQ ID No 2 for manufacturing a medicament for preventing or treating a cancer.
Claims14
1-11. (canceled)
A method of treating a cancer, comprising administering to a subject in need thereof a non-glycanated form of a polypeptide comprising an amino acid sequence having at least 90% amino acid identity with an amino acid sequence selected from the group consisting of SEQ ID No 1 and SEQ ID No 2.
A non-glycanated comprising an amino acid sequence selected from the group consisting of SEQ ID No 7 and SEQ ID No 8.
A pharmaceutical composition comprising a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID No 5, 6, 7 and 8.
Dependencies are inferred from the claim text.